CUC Inc. (JP:9158)
:9158
Want to see JP:9158 full AI Analyst Report?
Top Page
CUC Inc.
(9158)
Select Model
Select Model
Rating:56Neutral
Price Target:
¥743.00
▼(-12.38% Downside)
Action:Reiterated
Date:05/08/26
The score is weighed down by weak cash generation (low cash conversion and multi-year negative free cash flow) and rising leverage, alongside very bearish technicals with the price far below key moving averages. These risks are partly offset by a very low P/E and improved revenue growth.
Positive Factors
Revenue growth acceleration
Sustained acceleration in top-line growth indicates improving market demand and service uptake in the core medical-care business. Stronger revenue momentum supports scale benefits, better capacity utilization, and creates a foundation for longer-term margin recovery and investment.
Negative Factors
Weak cash generation; negative FCF
Multi-year negative free cash flow signals that operations and investments are not generating surplus cash, increasing reliance on external funding. Over time this limits ability to invest, raises refinancing needs, and magnifies risk given less internal liquidity to absorb demand or cost shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth acceleration
Sustained acceleration in top-line growth indicates improving market demand and service uptake in the core medical-care business. Stronger revenue momentum supports scale benefits, better capacity utilization, and creates a foundation for longer-term margin recovery and investment.
Read all positive factors
CUC Inc. (9158) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥21.02B
Dividend YieldN/A
Average Volume (3M)143.75K
Price to Earnings (P/E)4.5
Beta (1Y)1.01
Revenue Growth15.54%
EPS Growth-8.85%
CountryJP
Employees3,743
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)80.95
Shares Outstanding29,990,400
10 Day Avg. Volume142,970
30 Day Avg. Volume143,746
Financial Highlights & Ratios
PEG Ratio-1.01
Price to Book (P/B)0.77
Price to Sales (P/S)0.47
P/FCF Ratio-28.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)94.84
Revenue Forecast (FY)¥61.27B
CUC Inc. Business Overview & Revenue Model
Company Description
CUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consu...
How the Company Makes Money
null...
CUC Inc. Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
56
Neutral
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.44B | 54.35B | 47.04B | 33.02B | 35.21B | 35.31B |
| Gross Profit | 21.32B | 25.41B | 19.90B | 14.12B | 12.55B | 13.18B |
| EBITDA | 7.87B | 8.51B | 8.08B | 5.52B | 4.93B | 6.53B |
| Net Income | 2.37B | 2.85B | 3.13B | 2.60B | 2.42B | 2.71B |
Balance Sheet | ||||||
| Total Assets | 86.17B | 98.05B | 85.17B | 62.84B | 39.75B | 34.53B |
| Cash, Cash Equivalents and Short-Term Investments | 7.04B | 15.84B | 7.53B | 8.26B | 4.12B | 4.36B |
| Total Debt | 45.36B | 52.53B | 43.54B | 26.72B | 21.45B | 14.90B |
| Total Liabilities | 56.07B | 64.16B | 54.88B | 34.83B | 27.83B | 24.85B |
| Stockholders Equity | 29.54B | 33.25B | 29.68B | 27.32B | 11.70B | 9.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -912.00M | -3.04B | -703.00M | -3.10B | 5.79B |
| Operating Cash Flow | 0.00 | 5.71B | 2.50B | 4.16B | 2.36B | 6.62B |
| Investing Cash Flow | 0.00 | -3.38B | 4.45B | -14.75B | -6.68B | -1.47B |
| Financing Cash Flow | 0.00 | 5.92B | -7.60B | 14.37B | 3.97B | -4.43B |
CUC Inc. Technical Analysis
Neutral
848.00
Price Trends
932.32
Positive
912.34
Positive
1024.46
Negative
Market Momentum
38.93
Negative
59.89
Neutral
52.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9158, the sentiment is Neutral. The current price of 848 is below the 20-day moving average (MA) of 960.30, below the 50-day MA of 932.32, and below the 200-day MA of 1024.46, indicating a neutral trend. The MACD of 38.93 indicates Negative momentum. The RSI at 59.89 is Neutral, neither overbought nor oversold. The STOCH value of 52.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9158.
CUC Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥40.86B | 11.51 | ― | 2.63% | 3.49% | -14.24% | |
62 Neutral | ¥5.92B | 11.40 | ― | ― | 14.86% | 7.83% | |
59 Neutral | ¥2.35B | 4.69 | ― | 4.76% | 1.88% | 17.79% | |
56 Neutral | ¥21.02B | 4.49 | ― | ― | 15.54% | -8.85% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥5.56B | 23.20 | ― | 4.07% | 4.75% | 20.56% | |
45 Neutral | ¥6.13B | 19.08 | ― | 1.41% | 16.83% | -45.33% |
* Healthcare Sector Average
JP:9158
CUC Inc.
717.00
-334.00
-31.78%
JP:2373
Care Twentyone Corporation
413.00
28.02
7.28%
JP:2435
Cedar. Co.,Ltd
209.00
-27.44
-11.61%
JP:6062
Charm Care Corporation
1,253.00
80.56
6.87%
JP:7061
Japan Hospice Holdings Inc.
725.00
-423.08
-36.85%
JP:7091
Living Platform Ltd.
1,319.00
330.17
33.39%
CUC Inc. Corporate Events
CUC Inc. Profit Falls on Strategic Fee Cuts and Absence of Large M&A Fees
Apr 30, 2026
CUC Inc. reported a year-on-year decline in non-consolidated results for the fiscal year ended March 31, 2026, with revenue down 7.0% to 7,390 million yen and net income falling 33.4% to 949 million yen, translating to earnings of 32.38 yen per sh...
CUC Posts Revenue Growth but Projects Sharp Profit Decline as Investments Weigh on Earnings
Apr 30, 2026
CUC Inc. reported consolidated revenue of ¥54.35 billion for the year ended March 31, 2026, up 15.5% year on year, while operating profit rose 8.2% to ¥5.78 billion but profit before taxes and net income declined 2.6% and 10.9%, respecti...
CUC to Sell Medical-Focused Tokyo Real Estate, Booking ¥1.4 Billion Gain
Mar 19, 2026
CUC Inc. has approved the sale of trust beneficiary rights in land located in Shinjuku, Tokyo, held by its real estate leasing subsidiary CUC Properties Inc., to Fuyo General Lease Co., Ltd. for ¥3.4 billion, realizing an estimated gain on sa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.